Zymofix
ActiveThe annual accounts of Zymofix for fiscal year 2025 show a net loss of 51% of the equity at the start of that year. The 2025 annual accounts show equity of €1.58M and a net result of €-637k. Equity is growing by ~76.9% per year across the filed fiscal years. Its solvency ranks better than 61% of 190 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.0% (low).
Checked score
Score 2025
59
/ 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. A net loss of at least half of total assets or of the equity at the start of the financial year caps the score. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0=
Solvency91▲+9
Growth52=
Track record94
Bankruptcy probability, 12 months
1.0%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €90k at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity ample (current ratio 2.79 against 6.64 in 2024; short-term debt: 23.9% and cash: 44.1% of total assets), and 34.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
65.5%
Return on assets
-26.4%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
3 d early
2024
6 d early
2023
5 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-637k▼ 23.6%
2024 · €-515k
2023: €-408k
2024: €-515k
2023 → 2025
Working capital
€1.03M▼ 30.5%
2024 · €1.48M
2023: €-336k
2024: €1.48M
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€-346k-€1.25M€1.58M▲ 26.1%
Operating result€-393k-€-515k▼ 31.0%€-696k▼ 35.2%
Net result€-408k-€-515k▼ 26.3%€-637k▼ 23.6%
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €696k in 2025 against €515k in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.41M
Fixed assets
€803k▲ 72.1%
Current assets
€1.61M▼ 7.9%
Equity and liabilities €2.41M
Equity
€1.58M▲ 26.1%
Debt
€832k▼ 13.4%
The debt ratio falls from 43.4% to 34.5%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€-632k▼
2024 · €-496k
Cash flow
€-573k▼
2024 · €-496k
Solvency
65.5%▲
2024 · 56.6%
Current ratio
2.79▼
2024 · 6.64
Quick ratio
2.79▼
2024 · 6.64
Debt / equity
0.53▼
2024 · 0.77
ROE
-40.3%▲
2024 · -41.1%
ROA
-26.4%▼
2024 · -23.3%
Interest coverage
-224.36▼
2024 · -28.26
Debt
€832k▼
2024 · €960k
Debt ≤ 1 year
€578k▲
2024 · €263k
Income taxes
€98▼
2024 · €367
Staff costs
€780k▲
2024 · €290k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€2.21M€2.41M▲
Fixed assets21/28€467k€803k▲
Tangible fixed assets22/27€467k€803k▲
Plant, machinery and equipment23€451k€783k▲
Furniture and vehicles24€15k€20k▲
Current assets29/58€1.75M€1.61M▼
Amounts receivable within one year40/41€69k€542k▲
Trade receivables40€4k€92k▲
Other amounts receivable41€64k€450k▲
Current investments50/53€1.00M-
Cash at bank and in hand54/58€675k€1.06M▲
Deferred charges and accrued income490/1€4k€5k▲
Equity and liabilities
Total equity and liabilities10/49€2.21M€2.41M▲
Equity10/15€1.25M€1.58M▲
Contributions10/11€1.73M€2.53M▲
Capital10€1.73M€2.53M▲
Issued capital100€1.73M€2.53M▲
Profit (loss) carried forward14€-923k€-1.56M▼
Investment grants15€451k€615k▲
Amounts payable17/49€960k€832k▼
Amounts payable within one year42/48€263k€578k▲
Trade debts44€219k€463k▲
Suppliers440/4€219k€463k▲
Taxes, remuneration and social security45€44k€115k▲
Taxes450/3€67-
Remuneration and social security454/9€44k€115k▲
Accrued charges and deferred income492/3€697k€254k▼
Income statement
Code20242025
Remuneration, social security and pensions62€290k€780k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€19k€64k▲
Other operating charges640/8€978€838▼
Non-recurring operating charges66A€130€1k▲
Gross operating margin9900€-204k€150k▲
Operating profit (loss)9901€-515k€-696k▼
Financial income75/76B€17k€62k▲
Recurring financial income75€17k€62k▲
Financial charges65/66B€18k€3k▼
Recurring financial charges65€18k€3k▼
Profit (loss) for the period before taxes9903€-515k€-637k▼
Income taxes67/77€367€98▼
Profit (loss) for the period9904€-515k€-637k▼
Profit (loss) for the period to be appropriated9905€-515k€-637k▼
Appropriation of the result
Profit (loss) to be appropriated9906€-923k€-1.56M▼
Profit (loss) brought forward from the previous period14P€-408k€-923k▼
Social balance
Average headcount (FTE)9087-12.4
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
State Gazette act
Capital & shares · Statutes amendment · Resignations & appointmentsGeneral meeting · Capital increase · Capital26 facts ▸
State Gazette act
Capital & shares · Statutes amendment · Resignations & appointments
General meeting · Capital increase · Capital26 facts ▸
- General meeting, 2026-07-24
- Capital increase, €546.203,69
- Capital increase, €3.453.752,15
- Capital, €6.526.175,84
- Corporate purpose, onderzoek, de ontwikkeling, de productie, de installatie, de promotie, de distributie, de verkoop en het onderhoud van verwerkingstoepassingen voor biomassa waa…
- Statutes amendment
- Power of attorney, Zymofix
- Share issue, subscription rights, 14654
- Director resignation, CRESCENDO (bestuurder)
- Director resignation, Redemi (bestuurder)
- Director resignation, D.C. Beheer (bestuurder)
- Director resignation, Biotope Ventures (bestuurder)
- +14 further facts in this act
28-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial
Weakest financial yearnet €-637k
Net result drops to €-637k, the lowest in the series.
25-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity times 59current ratio 6.64
Current ratio from 0.11 to 6.64; short-term debt falls from €379k to €263k.
31-12
Financial
Equity above €1MEq €1.25M
Equity rises from €-346k to €1.25M.
26-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
under verification, no change since 2026
This board is reconstructed from a single act (26356311). A Gazette act generally publishes only CHANGES, not a full roll call, so directors unchanged since then may be missing here. The KBO register holds the complete list of function holders.
Biotope Ventures
CurrentDirector · since 24-07-2026 · Private limited company · perm. rep.: Annick VERWEEN
Boris DORIN
CurrentDirector · since 24-07-2026
CRESCENDO
CurrentDirector · since 24-07-2026 · Private limited company · perm. rep.: Herman VAN MELLAERT
D.C. Beheer
CurrentDirector · since 24-07-2026 · Public limited company · perm. rep.: Guy DE CLERCQ
Redemi
CurrentDirector · since 24-07-2026 · Limited partnership · perm. rep.: Emile REDANT
24-07-2026
Biotope Ventures: Appointed as Director
24-07-2026
Biotope Ventures: Resigned as Director
24-07-2026
Boris DORIN: Appointed as Director
24-07-2026
CRESCENDO: Appointed as Director
24-07-2026
CRESCENDO: Resigned as Director
24-07-2026
D.C. Beheer: Appointed as Director
24-07-2026
D.C. Beheer: Resigned as Director
24-07-2026
Redemi: Resigned as Director
24-07-2026
Redemi: Appointed as Director
Location & real-estate footprint
Registered office, Gent · 2 establishment units since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Waterlelielaan 19032 GentGround area
7,196 m²
Building footprint
427 m²
Volume, LiDAR
846 m³
2 parcels, Flanders · tallest building 11.1 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
N-Fix
since 20222.343.258.593
Operations
since 20232.363.324.925
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44074C0050/00H000 | Flanders | 5,728 m² | 1 · 268 m² | - |
| 44049C0162/00C002 | Flanders | 1,469 m² | 1 · 159 m² | 11.1 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Structure & network
Connections & network
3 connected companiesNetwork connections
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Ownership & control
4 partiesControl over this companysits on this company's board4
4 subsidiaries · 1 location
1 subsidiary · 1 location
1 subsidiary · 1 location
1 subsidiary · 1 location
controls
ZymofixBE 0788.847.055
Capital and shareholders
Capital increase of 546,203.69 EUR · 58,616 new shares · 68.24 EUR per share
Capital increase of 3,453,752.15 EUR
Capital increase
From the act
“De vergadering besluit, onder de opschortende voorwaarde en naarmate van de uitoefening van de Inschrijvingsrechten, tot een verhoging van het kapitaal van de vennootschap tot beloop van het maximumbedrag gelijk aan het aantal Inschrijvingsrechten (zijnde bij de uitgifte veertienduizend zeshonderdvijftig (14.654)), vermenigvuldigd met de toepasselijke uitoefenprijs, door uitgifte van maximaal veertienduizend zeshonderdvijftig (14.654) Common Shares van dezelfde aard en met dezelfde rechten en voordelen als de bestaande aandelen van dezelfde soort. Er wordt verduidelijkt dat de kapitaalverhogin”
Public money · subsidies and aid
Flemish government
2022 to 2025 · 11 entries · 493,034 EUR awarded · 405,986 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 3 | 483 EUR | 173,000 EUR |
| 2024 | 4 | 8,936 EUR | 183,214 EUR |
| 2023 | 3 | 433,615 EUR | 24,772 EUR |
| 2022 | 1 | 50,000 EUR | 25,000 EUR |
Schemes
Ontwikkelingsproject
O&O-haalbaarheidsstudie
Subsidies voor internationaal ondernemen
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
European Union, budget
2024 · 2 entries · 2,920,280 EUR in total| Year | Entries | awarded |
|---|---|---|
| 2024 | 2 | 2,920,280 EUR |
Projects
101144502 - N-SPIRE - NOVEL AND SCALABLE MICROBIAL PRODUCTS FOR REGENERATIVE AGRICULTURE
101161143 - I3-4-BIOFERTILIZERS - I3-4-BIOFERTILIZERS: INTERREGIONAL INNOVATION INVESTMENTS FOR BIOFERTILIZERS AND CIRCULAR BIOECONOMY SOLUTIONS FOR A SUSTAINABLE AGRICULTURE
European research
1 project · 1 as coordinator · 2,499,999 EUR EU contributionProgrammes
HORIZON
Projects
Novel and Scalable microbial products for REgenerative agriculture
Recognitions · licences · registrations
Food safety, FASFC
1 siteDeinze2.363.324.925
Similar companies · same sector, comparable size
Matthys Charlotte
BE 0835.964.410
Aalter · Eq €1.59M
EUROFINS FOOD TESTING BELGIUM
BE 0831.186.664
Nazareth-De Pinte · Eq €1.59M
ReWind Therapeutics
BE 0682.626.216
Leuven · Eq €1.63M
ASTERION RESEARCH & DEVELOPMENT
BE 0682.704.608
Gent · Eq €1.64M
RUMEXPERTS
BE 0742.532.822
Faimes · Eq €1.65M
Of 761 companies in sector 72101 we hold annual accounts for 481. 274 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded25-07-2022
Fiscal year end31-12
Activities, NACEBEL
72101Research and development on biotechnology
72109Other research and development on natural sciences
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.